Portugal Becomes EMA’s Latest Suitor As Agency Cost Pressures Grow
Portuguese officials are visiting the European Medicines Agency to tout the merits of Lisbon as its future home, but the financial pressures of Brexit are becoming clearer after the EMA management board said it could no longer set aside a special provision to cover the relocation costs.
You may also be interested in...
The leader of Denmark’s bid to host the European Medicines Agency after the UK leaves the EU says that a rapid decision-making process on the agency’s new location is needed in order to avoid entanglements with the wider Brexit negotiations, and that a decision could be taken sometime in the second half of this year.
The European Medicines Agency is working to ensure it can cope with the many challenges it will face as a result of the UK leaving the EU. Those challenges could include the agency losing 50% of its staff, according to the EMA’s deputy head Noel Wathion.
Members of the European Parliament committee charged with leading the negotiations on the review of the EU pharmaceutical legislation have been presented with a study backing cuts in data protection and wider joint procurement of medicines outside emergency situations.